Skip to main content
Toggle navigation
Search
Home
Back
13 Views
Email
Tumor
Bioengineered TLR9 Agonist Crosses the Blood Brain Barrier to Induce Intratumoral Antigen Presentation in Brain Tumors
Presenting Author(s)
Alexander L. Ren, MPhil
Medical Student
Stanford University School of Medicine
.jpg)
